DK0970130T3 - Glycosaminoglycaner med høj antithrombotisk aktivitet - Google Patents

Glycosaminoglycaner med høj antithrombotisk aktivitet

Info

Publication number
DK0970130T3
DK0970130T3 DK98917065T DK98917065T DK0970130T3 DK 0970130 T3 DK0970130 T3 DK 0970130T3 DK 98917065 T DK98917065 T DK 98917065T DK 98917065 T DK98917065 T DK 98917065T DK 0970130 T3 DK0970130 T3 DK 0970130T3
Authority
DK
Denmark
Prior art keywords
glycosaminoglycans
antithrombotic activity
high antithrombotic
salt
resulfation
Prior art date
Application number
DK98917065T
Other languages
Danish (da)
English (en)
Inventor
Benito Casu
Annamaria Naggi
Giangiacomo Torri
Original Assignee
Inalco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inalco Spa filed Critical Inalco Spa
Application granted granted Critical
Publication of DK0970130T3 publication Critical patent/DK0970130T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK98917065T 1997-03-24 1998-03-24 Glycosaminoglycaner med høj antithrombotisk aktivitet DK0970130T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI000678A IT1290814B1 (it) 1997-03-24 1997-03-24 Glicosaminoglicani aventi elevata attivita' antitrombotica
PCT/EP1998/001714 WO1998042754A2 (en) 1997-03-24 1998-03-24 Glycosaminoglycans having high antithrombotic activity

Publications (1)

Publication Number Publication Date
DK0970130T3 true DK0970130T3 (da) 2002-11-04

Family

ID=11376585

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98917065T DK0970130T3 (da) 1997-03-24 1998-03-24 Glycosaminoglycaner med høj antithrombotisk aktivitet

Country Status (12)

Country Link
US (1) US6197943B1 (ko)
EP (1) EP0970130B1 (ko)
JP (1) JP2001518133A (ko)
KR (1) KR20000075663A (ko)
AT (1) ATE220410T1 (ko)
AU (1) AU7040598A (ko)
CA (1) CA2285383C (ko)
DE (1) DE69806468T2 (ko)
DK (1) DK0970130T3 (ko)
ES (1) ES2180161T3 (ko)
IT (1) IT1290814B1 (ko)
WO (1) WO1998042754A2 (ko)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2161615B1 (es) * 1999-07-23 2003-03-16 Rovi Lab Farmaceut Sa Composiciones de heparinas de muy bajo peso molecular.
US6977248B1 (en) * 1999-08-25 2005-12-20 Massachusetts Institute Of Technology Pharmaceutical preparations for the inhibition of herpes simplex virus 1 entry
US20020062019A1 (en) * 2000-03-30 2002-05-23 Pasqua Oreste Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation
US8227449B2 (en) * 2000-03-30 2012-07-24 Glycores 2000 S.R.L. Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation
IT1318432B1 (it) * 2000-03-30 2003-08-25 Inalco Spa Glicosaminoglicani derivati dal polisaccaride k5 aventi elevataattivita' anticoagulante ed antitrombotica e processo per la loro
JP2002080371A (ja) * 2000-06-23 2002-03-19 Seikagaku Kogyo Co Ltd プラスミノーゲンアクチベーター活性促進剤
US6969705B2 (en) * 2000-07-21 2005-11-29 Aventis Pharma S.A. Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
ITMI20010397A1 (it) * 2001-02-27 2002-08-27 Giorgio Zoppetti Derivati altamente n,o-solfatati del polisaccaride k5 e loro preparazione
ITMI20011633A1 (it) * 2001-07-27 2003-01-27 San Raffaele Centro Fond Uso di polisaccaridi batterici supersolfatati inibitori dell'hiv
US7575886B2 (en) 2002-03-11 2009-08-18 Momenta Pharmaceuticals, Inc. Analysis of sulfated polysaccharides
US20120253029A1 (en) 2002-06-18 2012-10-04 Pasqua Anna Oreste Process for the preparation of highly o-sulfated epimerized derivatives of k5 polysaccharide and intermediates therein
PL375087A1 (en) 2002-06-18 2005-11-14 Glycores 2000 S.R.L. Low molecular weight oversulfated polysaccharide
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
US7956046B2 (en) * 2003-07-24 2011-06-07 Aventis Pharma S.A. Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
ITMI20031618A1 (it) * 2003-08-06 2005-02-07 Inalco Spa Derivati polisaccaridici dotati di alta attivita'
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
AU2008100730B4 (en) * 2008-07-04 2008-10-02 Parnell Technologies Pty Ltd Sulfated polysaccharide compound for clinical use and the preparation thereof
WO2011090948A1 (en) * 2010-01-19 2011-07-28 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
EP4326782A1 (en) 2021-05-12 2024-02-28 Nexeos Diagnostics, Inc. Methods of manufacturing a high molecular weight heparin compound

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281108A (en) * 1980-01-28 1981-07-28 Hepar Industries, Inc. Process for obtaining low molecular weight heparins endowed with elevated pharmacological properties, and product so obtained
FR2538404B1 (ko) * 1982-12-28 1985-08-23 Anic Spa
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
GB8519416D0 (en) * 1985-08-01 1985-09-04 Unilever Plc Oligosaccharides
EP0333243A3 (en) * 1988-03-10 1989-09-27 Akzo N.V. Sulphated k5 antigen and sulphated k5 antigen fragments
IT1217458B (it) * 1988-05-02 1990-03-22 Crinos Ind Farmacoriologica S Sulfoamino derivati di condroitin solfati,del dermatan solfato e dell' acido ialuronico e loro proprieta' farmacologiche
IT1237518B (it) * 1989-11-24 1993-06-08 Renato Conti Eparine supersolfatate
JPH04202401A (ja) * 1990-11-30 1992-07-23 Terumo Corp ヘパリン誘導体の製造法
FR2669932B1 (fr) * 1990-12-03 1994-07-01 Sanofi Sa Nouvel heparosane-n,o-sulfate, son procede de preparation et les compositions pharmaceutiques qui le contiennent.
FR2704861B1 (fr) * 1993-05-07 1995-07-28 Sanofi Elf Fractions d'héparine purifiées, procédé d'obtention et compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
JP2001518133A (ja) 2001-10-09
ES2180161T3 (es) 2003-02-01
AU7040598A (en) 1998-10-20
KR20000075663A (ko) 2000-12-26
CA2285383A1 (en) 1998-10-01
US6197943B1 (en) 2001-03-06
ITMI970678A1 (it) 1998-09-24
ATE220410T1 (de) 2002-07-15
DE69806468T2 (de) 2003-02-27
EP0970130B1 (en) 2002-07-10
WO1998042754A3 (en) 1998-12-23
CA2285383C (en) 2006-09-26
WO1998042754A2 (en) 1998-10-01
IT1290814B1 (it) 1998-12-11
DE69806468D1 (de) 2002-08-14
EP0970130A2 (en) 2000-01-12

Similar Documents

Publication Publication Date Title
DK0970130T3 (da) Glycosaminoglycaner med høj antithrombotisk aktivitet
IT1316986B1 (it) Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica.
DE69704433T2 (de) Herstellung von kohlenwasserstofflöslichen hydrocarbylaluminoxanen
MX9700885A (es) Nuevas heteroariloxazolidinonas.
DK0944643T3 (da) Oxyiminopregnancarbolactoner.
ATE397005T1 (de) Sialyl-lewisa und sialyl-lewisx epitope analoge
FI951001A0 (fi) Sulfatoituja alfa-glykolipidijohdannaisia soluadheesioinhibiittoreina
MX9300777A (es) Derivados aminoacetilmercapto novedosos utiles como inhibidores de la encefalinasa y la eca
EA199900580A1 (ru) Фармацевтические производные аминофосфоновой кислоты
ATE247617T1 (de) Entzendungshemmende antibakterielle benzylphenolverbindungen
DE69034070T2 (de) Racemisches Huperzin A
FI920430A (fi) Benzyloxifenylderivator.
ES2165735T3 (es) Composicion que contiene dextrina para prevenir las adhesiones quirurgicas.
DK1059931T3 (da) Anvendelse af CD137 til fremme af perifere monocytters proliferation
BR9606955A (pt) Heterocicloalquenos substituísos
TR200002749T2 (tr) Antibiyotikler olarak siklik aminoguanidin substitüentlerine sahip sefalosporinler.
ES2117357T3 (es) Tetrahidrobenz(cd)indoles reguladores de la actividad de la serotonina.
RU2076517C1 (ru) Пищевой краситель
ES1026412Y (es) Instalacion para desollar conejos.
ES2183543T3 (es) Derivado de tiocolchicosida, su preparacion y su aplicacion en terapeutica.
ES2121685B1 (es) Procedimiento para la obtencion de (+)-trans-4(4-fluoro-fenil)-3-hidroximetil-1-metilpiperidina.
NO912276L (no) Heparinfragmenter som hemmere av proliferasjon av glatte muskelceller.
TH48395S (th) ขารางสำหรับใส่ขั้วรับหลอด
GR1001393B (el) Παράγωγα ιμιδαζο[2,1-Β] 3] βενζαζεπίνης, συν?έσεις και μέ?οδος χρήσεως.
UA36284A (uk) Візирний пристрій